Starling Oncology, Inc. (STLNW)
Nasdaq: STLNW · CIK 0001799191 · United States
Every official Starling Oncology, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open STLNW filings
Starling Oncology, Inc. documents
- Starling Oncology, Inc. 10-K 2026STLNW 10-K 2026: annual report for fiscal 2026
- Starling Oncology, Inc. 10-K 2025STLNW 10-K 2025: annual report for fiscal 2025
- Starling Oncology, Inc. 10-K 2024STLNW 10-K 2024: annual report for fiscal 2024
- Starling Oncology, Inc. 10-K 2023STLNW 10-K 2023: annual report for fiscal 2023
- Starling Oncology, Inc. 10-K 2022STLNW 10-K 2022: annual report for fiscal 2022
- Starling Oncology, Inc. 10-Q 2026STLNW 10-Q 2026: quarterly report for fiscal 2026
- Starling Oncology, Inc. 10-Q 2025STLNW 10-Q 2025: quarterly report for fiscal 2025
- Starling Oncology, Inc. 10-Q 2024STLNW 10-Q 2024: quarterly report for fiscal 2024
- Starling Oncology, Inc. 10-Q 2023STLNW 10-Q 2023: quarterly report for fiscal 2023
- Starling Oncology, Inc. 10-Q 2022STLNW 10-Q 2022: quarterly report for fiscal 2022
- Starling Oncology, Inc. 8-K 2026STLNW 8-K 2026: current report for fiscal 2026
- Starling Oncology, Inc. 8-K 2025STLNW 8-K 2025: current report for fiscal 2025
- Starling Oncology, Inc. 8-K 2024STLNW 8-K 2024: current report for fiscal 2024
- Starling Oncology, Inc. 8-K 2023STLNW 8-K 2023: current report for fiscal 2023
- Starling Oncology, Inc. 8-K 2022STLNW 8-K 2022: current report for fiscal 2022
- Starling Oncology, Inc. DEF 14A 2026STLNW DEF 14A 2026: proxy statement for fiscal 2026
- Starling Oncology, Inc. DEF 14A 2025STLNW DEF 14A 2025: proxy statement for fiscal 2025
- Starling Oncology, Inc. DEF 14A 2024STLNW DEF 14A 2024: proxy statement for fiscal 2024
- Starling Oncology, Inc. DEF 14A 2023STLNW DEF 14A 2023: proxy statement for fiscal 2023
- Starling Oncology, Inc. DEF 14A 2022STLNW DEF 14A 2022: proxy statement for fiscal 2022
- Starling Oncology, Inc. Form 4 2026STLNW Form 4 2026: insider trading filing for fiscal 2026
- Starling Oncology, Inc. Form 4 2025STLNW Form 4 2025: insider trading filing for fiscal 2025
- Starling Oncology, Inc. Form 4 2024STLNW Form 4 2024: insider trading filing for fiscal 2024
- Starling Oncology, Inc. Form 4 2023STLNW Form 4 2023: insider trading filing for fiscal 2023
- Starling Oncology, Inc. Form 4 2022STLNW Form 4 2022: insider trading filing for fiscal 2022
- Starling Oncology, Inc. S-1 2026STLNW S-1 2026: registration statement for fiscal 2026
- Starling Oncology, Inc. S-1 2025STLNW S-1 2025: registration statement for fiscal 2025
- Starling Oncology, Inc. S-1 2024STLNW S-1 2024: registration statement for fiscal 2024
- Starling Oncology, Inc. S-1 2023STLNW S-1 2023: registration statement for fiscal 2023
- Starling Oncology, Inc. S-1 2022STLNW S-1 2022: registration statement for fiscal 2022
- Starling Oncology, Inc. 13F 2026STLNW 13F 2026: institutional holdings for fiscal 2026
- Starling Oncology, Inc. 13F 2025STLNW 13F 2025: institutional holdings for fiscal 2025
- Starling Oncology, Inc. 13F 2024STLNW 13F 2024: institutional holdings for fiscal 2024
- Starling Oncology, Inc. 13F 2023STLNW 13F 2023: institutional holdings for fiscal 2023
- Starling Oncology, Inc. 13F 2022STLNW 13F 2022: institutional holdings for fiscal 2022
More companies